Metraipolis › archive › dc_435d4eecc0b9
Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study — Europe PMC PMID:40947139
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40947139
- DOI
- 10.1002/pds.70214
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:40:20.544Z
- SHA-256 of the archived text
dcd5571b136edc030b9bea4492d8cfdd8a11067c032dd09fe7bc3f4e359f15d7- Stable URL of this page
https://metraipolis.com/documento/dc_435d4eecc0b9
How to cite
Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study — Europe PMC PMID:40947139 — Europe PMC (en), https://europepmc.org/article/MED/40947139 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_435d4eecc0b9 (Metraipolis archive dc_435d4eecc0b9, sha256 dcd5571b136edc030b9bea4492d8cfdd8a11067c032dd09fe7bc3f4e359f15d7)
BibTeX
@misc{dc435d4eecc0b9,
title = {Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study — Europe PMC PMID:40947139},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40947139},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_435d4eecc0b9; sha256 dcd5571b136edc030b9bea4492d8cfdd8a11067c032dd09fe7bc3f4e359f15d7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40947139. Agents can read the archived copy with the MCP tool read_document.